Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimal glucocorticoid replacement in ACTH-deficient hypopituitarism
2007-005018-37Phase 4Completed
- Sponsor
- Amar Agha
- Start
- Sep 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of hydrocortisone in hypopituitarism, sponsored by Amar Agha. Primary endpoint: Physiological hydrocortisone replacement dose identification. Started Sep 2007; status: completed.
02
Drugs
hydrocortisone
03
Conditions
hypopituitarism
Beyond the preview
Go deeper on 2007-005018-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005018-37.